Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference?
- 1 August 2000
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 29 (2) , 91-104
- https://doi.org/10.1016/s0169-5002(00)00112-4
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Revisions in the International System for Staging Lung CancerChest, 1997
- Should non-small cell carcinoma of the lung be treated with chemotherapy? Con: therapeutic empiricism--the case against chemotherapy in non-small cell lung cancer.American Journal of Respiratory and Critical Care Medicine, 1995
- Should non-small cell carcinoma of the lung be treated with chemotherapy? Pro: chemotherapy is for non-small cell lung cancer.American Journal of Respiratory and Critical Care Medicine, 1995
- Incidence of local recurrence and second primary tumors in resected stage I lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Cancer statistics, 1993CA: A Cancer Journal for Clinicians, 1993
- Chemotherapy of Lung CancerNew England Journal of Medicine, 1992
- Chemotherapy and Survival in Non-Small Cell Lung CancerChest, 1991
- Chemotherapy for Non-Small Cell Lung CancerChest, 1991
- Chemotherapy and Survival of Patients with Non-Small Cell Lung CancerChest, 1991
- Retrospective and prospective tumor staging evaluating prognostic factors in operated bronchus carcinoma patientsCancer, 1987